Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.

ETHNOPHARMACOLOGICAL RELEVANCE: Withania somnifera (L.) Dunal; (Solanaceae), commonly known as Ashwagandha, is one of the most significant medicinal herbs in 'Ayurveda', a traditional Indian medicine used for centuries with evidence in scriptures. Ashwagandha was mentioned in old Ayurvedic medical literature such as Charaka Samhita and Sushruta Samhita for improving weight and strength, with multiple citations for internal and exterior usage in emaciation and nourishing the body. Ethnopharmacological evidence revealed that it was used to relieve inflammation, reduce abdominal swelling, as a mild purgative, and treat swollen glands. The root was regarded as a tonic, aphrodisiac, and emmenagogue in the Unani tradition of the Indian medicinal system. Further, Ashwagandha has been also described as an Ayurvedic medicinal plant in the Ayurvedic Pharmacopoeia of India extending informed therapeutic usage and formulations. Despite the widespread ethnopharmacological usage of Ashwagandha, clinical pharmacokinetic parameters are lacking in the literature; hence, the findings of this study will be relevant for calculating doses for future clinical evaluations of Ashwagandha root extract. AIM: This study aimed to develop a validated and highly sensitive bioanalytical method for quantifying withanosides and withanolides of the Ashwagandha root extract in human plasma to explore its bioaccessibility. Further to apply a developed method to perform pharmacokinetics of standardized Withania somnifera (L.) Dunal root extract (WSE; AgeVel®/Witholytin®) capsules in healthy human volunteers. METHODS: A sensitive, reliable, and specific ultra-high pressure liquid chromatography-mass spectrometry (UHPLC-MS/MS) method was developed and validated for the simultaneous quantification of five major withanosides and withanolides (withanoside IV, withanoside V, withanolide A, withaferin A, and 12-deoxy-withastramonolide) in human plasma. Further for the study, eighteen healthy male volunteers (18-45 years) were enrolled in a non-randomized, open-label, single period, single treatment, clinical pharmacokinetic study and given a single dose (500 mg) of WSE (AgeVel®/Witholytin®) capsules containing not less than 7.5 mg of total withanolides under fasting condition. Later, pharmacokinetic profiles were assessed using the plasma concentration of each bioactive constituent Vs. time data. RESULTS: For all five constituents, the bioanalytical method demonstrated high selectivity, specificity, and linearity. There was no carryover, and no matrix effect was observed. Furthermore, the inter-day and intra-day precision and accuracy results fulfilled the acceptance criteria. Upon oral administration of WSE capsules, Cmax was found to be 0.639 ± 0.211, 2.926 ± 1.317, 2.833 ± 0.981, and 5.498 ± 1.986 ng/mL for withanoside IV, withanolide A, withaferin A, and 12-deoxy-withastramonolide with Tmax of 1.639 ± 0.993, 1.361 ± 0.850, 0.903 ± 0.273, and 1.375 ± 0.510 h respectively. Further, withanoside V was also detected in plasma; but its concentration was found below LLOQ. CONCLUSION: The novel and first-time developed bioanalytical method was successfully applied for the quantification of five bio-active constituents in human volunteers following administration of WSE capsules, indicating that withanosides and withanolides were rapidly absorbed from the stomach, have high oral bioavailability, and an optimum half-life to produce significant pharmacological activity. Further, AgeVel®/Witholytin® was found safe and well tolerated after oral administration, with no adverse reaction observed at a 500 mg dose.

Influence of pressure on a dysprosocenium single-molecule magnet.

The effects of external pressure on a high-performing dysprosocenium single-molecule magnet are investigated using a combination of X-ray diffraction, magnetometry and theoretical calculations. The effective energy barrier (Ueff) decreases from ca. 1300 cm-1 at ambient pressure to ca. 1125 cm-1 at 3 GPa. Our results indicate that compression < 1.2 GPa has a negligible effect on the Orbach process, but magnetic relaxation > 1 GPa increases via Raman relaxation and/or quantum tunnelling of magnetisation.

A Cost-Effective Semi-Ab Initio Approach to Model Relaxation in Rare-Earth Single-Molecule Magnets.

We discuss a cost-effective approach to understand magnetic relaxation in the new generation of rare-earth single-molecule magnets. It combines ab initio calculations of the crystal field parameters, of the magneto-elastic coupling with local modes, and of the phonon density of states with fitting of only three microscopic parameters. Although much less demanding than a fully ab initio approach, the method gives important physical insights into the origin of the observed relaxation. By applying it to high-anisotropy compounds with very different relaxation, we demonstrate the power of the approach and pinpoint ingredients for improving the performance of single-molecule magnets.

Slow magnetic relaxation in distorted tetrahedral Dy(III) aryloxide complexes.

Three distorted tetrahedral Dy(III) aryloxide complexes, [Na(THF)6][Dy(OArAd2tBu)2Cl2] (1) (OArAd2tBu = OC6H2Adamantyl2-2,6-tBu-4) and [Na(THF)6][Dy(OMes*)3X] (X = Cl, 2; BH4, 3), (OMes* = OC6H2tBu3-2,4,6) exhibit easy axis magnetic anisotropy and slow magnetic relaxation at zero field, with relaxation rates 1 < 2 < 3.

Development of a loop-mediated isothermal amplification assay based on RoTat1.2 gene for detection of Trypanosoma evansi in domesticated animals.

The early containment of trypanosomosis depends on early, sensitive, and accurate diagnosis in endemic areas with low-intensity infections. The study was planned to develop a simple read out loop-mediated isothermal amplification (LAMP) assay targeting a partial RoTat1.2 VSG gene of Trypanosoma evansi with naked eye visualization of LAMP products by adding SYBR® Green I dye. The visual results were further confirmed with those of agarose gel electrophoresis, restriction enzyme digestion of LAMP products with AluI, and sequencing of the PCR products using LAMP outer primers. The LAMP primers did not show cross reactivity and non-specific reactions with regional common hemoparasitic DNA revealing high specificity of the assay. The threshold sensitivity level of the LAMP assay was determined to be 0.003 fg compared to 0.03 fg RoTat1.2 amplified DNA fragments of T. evansi by PCR assay. Moreover, assessment of 500 blood samples collected from unhealthy domestic animals in field suspected for various hemoparasitic infections was carried out for the presence of T. evansi by microscopy, RoTat1.2 VSG PCR, and LAMP assay. LAMP could detect T. evansi in 36 samples, while PCR and microscopy could detect 33 and 12 samples, respectively. All the samples positive by microscopy and PCR were also confirmed positive by the LAMP assay. The current LAMP assay has appealing point of care characteristics to visually monitor the results, lessen the need of post DNA amplification procedure, and enable this method to be applied as a rapid and sensitive molecular diagnostic tool in under resourced laboratories and field setup.

Mononuclear Dysprosium Alkoxide and Aryloxide Single-Molecule Magnets.

Recent studies have shown that mononuclear lanthanide (Ln) complexes can be high-performing single-molecule magnets (SMMs). Recently, there has been an influx of mononuclear Ln alkoxide and aryloxide SMMs, which have provided the necessary geometrical control to improve SMM properties and to allow the intricate relaxation dynamics of Ln SMMs to be studied in detail. Here non-aqueous Ln alkoxide and aryloxide chemistry applied to the synthesis of low-coordinate mononuclear Ln SMMs are reviewed. The focus is on mononuclear DyIII alkoxide and aryloxide SMMs with coordination numbers up to eight, covering synthesis, solid-state structures and magnetic attributes. Brief overviews are also provided of mononuclear TbIII , HoIII , ErIII and YbIII alkoxide and aryloxide SMMs.

Probing Relaxation Dynamics in Five-Coordinate Dysprosium Single-Molecule Magnets.

A new family of five-coordinate lanthanide single-molecule magnets (Ln SMMs) [Dy(Mes*O)2 (THF)2 X] (Mes*=2,4,6-tri-tert-butylphenyl; X=Cl, 1; Br, 2; I, 3) is reported with energy barriers to magnetic reversal >1200 K. The five-coordinate DyIII ions have distorted square pyramidal geometries, with halide anions on the apex, and two Mes*O ligands mutually trans- to each other, and the two THF molecules forming the second trans- pair. These geometrical features lead to a large magnetic anisotropy in these complexes along the trans-Mes*O direction. QTM and Raman relaxation times are enhanced by varying the apex halide from Cl to Br to I, or by dilution in a diamagnetic yttrium analogue.

Adverse drug reactions and risk factors for discontinuation of multidrug-resistant tuberculosis regimens in Gujarat, western India.

Background: The predictors for discontinuation of multidrug-resistant tuberculosis (MDR-TB) regimens have not been studied in Gujarat. We aimed to find out the adverse drug reactions (ADRs) and predictors for discontinuation of MDR-TB regimens. Methods: We conducted this cross-sectional study in Bhavnagar district of Gujarat from September to November 2016 through home visits and personal interviews of 94 patients with MDR-TB. Results: Sixty-nine patients with MDR-TB (73%) reported ADRs. Tingling (42.6%), headache (37.2%), numbness (36.2%), dizziness (34%) and nausea (33%) were the most common ADRs. Of the 94 patients, 7.4% were compelled to think of discontinuing their treatment due to ADRs; 8.5% had discontinued Cat-I/Cat-II regimen in the past; 11.7% had discontinued their MDR-TB regimen in the past; 13.8% had their drug regimen changed due to ADRs and 94.7% had good adherence to their current regimen (took at least 80% of their doses till date). ADRs were the reason for 75% of the patients who discontinued their Cat-I/Cat-II regimen in the past and 64% of the patients who discontinued their MDR-TB regimen in the past. Tobacco chewing, poor adherence and thought of discontinuing an MDR-TB regimen due to ADRs were significant predictors for discontinuation on bivariate analysis. On multiple logistic regression, none of the predictors were significant. Conclusions: The frequency of ADRs among patients with MDR-TB is high. ADRs were the primary reason for discontinuing MDR-TB drugs.

Application of Cocrystallization Approach in Drug Development: Recent Patents Review.

BACKGROUND: Cocrystals of active pharmaceutical ingredient has been of interest in the field of pharmaceutical research due to their potential for tailoring the physicochemical properties of pharmaceutical molecules. The increase in number of cocrystals screening experiments being reported and simultaneously the draft guidelines issued from regulatory bodies on pharmaceutical cocrystals provide the evidence of the acceptance of cocrystals in the drug development. This review presents the numerous patents addressing the key properties of an active pharmaceutical ingredient namely solubility and stability towards varied environmental conditions, being modified using suitable coformer and appropriate cocrystallization technique. METHODS: A literature review was conducted to summarize the reported articles as well as patents that have been published and/or granted for work related to cocrystallization of an active pharmaceutical ingredient (API). Efforts have been made to include examples for various types of objectives undertaken by the researchers to cocrystallize an API. RESULTS: The summary of the various cocrystallization techniques reported in peer reviewed journals shows that a majority of the articles till date prefer and explore the slow solvent crystallization technique compared to solid-state mediated processes. Amongst all the patents summarized in the review article, 37 patents have been published along with the improvement in physicochemical properties of the API whereas 35 patents have been reported only for the process of preparation of the API. CONCLUSION: The contents of the review very well highlight the ever increasing scope for the cocrystallization technique of an API, the varied methodologies applied for cocrystallization and the properties that can be improved by cocrystallization.

Channel-Assisted Proton Conduction Behavior in Hydroxyl-Rich Lanthanide-Based Magnetic Metal-Organic Frameworks.

Two new lanthanide-based 3D metal-organic frameworks (MOFs), {[Ln(L)(Ox)(H2O)]n·xH2O} [Ln = Gd3+ and x = 3 (1) and Dy3+ and x = 1.5 (2); H2L = mucic acid; OxH2 = oxalic acid] showing interesting magnetic properties and channel-mediated proton conduction behavior, are presented here. Single-crystal X-ray structure analysis shows that, in complex 1, the overall structure originates from the mucate-bridged gadolinium-based rectangular metallocycles. The packing view reveals the presence the two types of hydrophilic 1D channels filled with lattice water molecules, which are strongly hydrogen-bonded with coordinated water along the a and b axes, whereas for complex 2, the 3D framework originates from a carboxylate-bridged dysprosium-based criss-cross-type secondary building block. Magnetic studies reveal that 1 exhibits a significant magnetic entropy change (-ΔSM) of 30.6 J kg-1 K-1 for ΔH= 7 T at 3 K. Our electronic structure calculations under the framework of density functional theory reveal that exchange interactions between Gd3+ ions are weak and of the antiferromagnetic type. Complex 2 shows field-induced single-molecule-magnetic behavior. Impedance analysis shows that the proton conductivity of both complexes reaches up to the maximum value of 4.7 × 10-4 S cm-1 for 1 and 9.06 × 10-5 S cm-1 for 2 at high temperature (>75 °C) and relative humidity (RH; 95%). The Monte Carlo simulations confirm the exact location of the adsorbed water molecules in the framework after humidification (RH = 95%) for 1. Further, the results from computational simulation also reveal that the presence of a more dense arrangement of adsorbed water molecules through hydrogen bonding in a particular type of channel (along the a axis) contributes more to the proton migration compared to the other channel (along the b axis) in the framework.

Tetrahedral M(II) based binuclear double-stranded helicates: single-ion-magnet and fluorescence behaviour.

A rare class of dinuclear double-stranded helicates having tetrahedral metal centres with formulae [Co2(L(1))2]·2(CH3CN) (1), [Co2(L(2))2]·6(CH3CN) (2), [Zn2(L(1))2]·2(CH3CN)·(CH3OH) (3) and [Zn2(L(2))2]·4(CH3CN) (4) were synthesized and characterized. Detailed dc and ac magnetic susceptibility measurements reveal the presence of field induced slow magnetic relaxation behaviour in high spin tetrahedral Co(II) centres with an easy-plane magnetic anisotropy. Complexes 1 and 2 are the rare examples of transition metal based helicates showing such behaviour. Furthermore, 3 and 4 exhibit fluorescence emission in different solvents that are analyzed in terms of fluorescence quantum yields and lifetimes.

A simple high-performance liquid chromatographic method for the estimation of boswellic acids from the market formulations containing Boswellia serrata extract.

A simple, rapid, and reproducible reverse-phase high-performance liquid chromatographic method is developed for the estimation of boswellic acids, the active constituents in Boswellia serrata oleo-gum resin. The chromatographic separation is performed using a mobile phase consisting of acetonitrile-water (90:10, % v/v) adjusted to pH 4 with glacial acetic acid on a Kromasil 100 C18 analytical column with flow rate of 2.0 mL/min and detection at 260 nm. The elution times are 4.30 and 7.11 min for 11-keto beta-boswellic acid (11-KBA) and 3-acetyl 11-keto beta-boswellic acid (A-11-KBA), respectively. The calibration curve is linear in the 11.66-58.30 microg/mL and 6.50-32.50 microg/mL range for 11-KBA and A-11-KBA, respectively. The limits of detection are 2.33 microg/mL and 1.30 microg/mL for 11-KBA and A-11-KBA, respectively. The mean recoveries are 98.24% to 104.17% and 94.12% to 105.92% for 11-KBA and A-11-KBA, respectively. The inter- and intra-day variation coefficients are less than 5%. The present method is successfully applied for the estimation of boswellic acids from the market formulations containing Boswellia serrata extract.

Preparation and characterization of etoricoxib-beta-cyclodextrin complexes prepared by the kneading method.

The binary system of etoricoxib with beta-cyklodextrin (beta-CD) was prepared by the kneading method. Drug-cyclodextrin interactions in solution were investigated by the phase solubility analysis. Differential scanning calorimetry, infrared spectroscopy, powder X-ray diffractometry and microscopic study were used to characterize the solid state of all binary systems, whereas their dissolution properties were evaluated according to the USP XXIII paddle method. The results indicate partial interaction of the drug with beta-CD in the physical mixture and complete interaction in the kneaded complex. The dissolution of etoricoxib was notably increased as compared to pure drug as well as its physical mixture. The complex showed more than 75% drug released in 30 min.

Estimation of boswellic acids from market formulations of Boswellia serrata extract and 11-keto beta-boswellic acid in human plasma by high-performance thin-layer chromatography.

A rapid and sensitive high-performance thin-layer chromatographic (HPTLC) method was developed and validated for the quantitative estimation of boswellic acids in formulation containing Boswellia serrata extract (BSE) and 11-keto beta-boswellic acid in human plasma. Simple extraction method was used for isolation of boswellic acid from formulation sample and acidified plasma sample. The isolated samples were chromatographed on silica gel 60F(254)-TLC plates, developed using ternary-solvent system (hexane-chloroform-methanol, 5:5:0.5, v/v) and scanned at 260 nm. The linearity range for 11-KBA spiked in 1 ml of plasma was 29.15-145.75 ng with average recovery of 91.66%. The limit of detection and limit of quantification for 11-KBA in human plasma were found to be 8.75 ng/ml and 29.15 ng/ml. The developed method was successfully applied for the assay of market formulations containing BSE and to determine plasma level of 11-keto beta-boswellic acid in a clinical pilot study.

Preparation and characterization of etoricoxib-polyethylene glycol 4000 plus polyvinylpyrrolidone K30 solid dispersions.

The objective of the present investigation was to study the influence of polyethylene glycol 4000 (PEG) and polyvinylpyrrolidone K30 (PVP) on in vitro dissolution of etoricoxib from solid dispersions. Preliminary studies were carried out using a physical mixture of the drug and carriers. Solid dispersions were prepared using the solvent evaporation method. A 32 factorial design was adopted in the solvent evaporation method using the concentration of PEG and PVP as independent variables. Full and reduced models were evolved for dependant variables, such as the percentage of drug release in 10 min (Q10), percentage of drug release in 30 min (Q30), percentage of drug release in 45 min (Q45) and percent dissolution efficiency (DE). The reduced models were validated using two check points. Q10 > 65%, Q30 > 75%, Q45 > 85% and DE > 80% were used as constraints for the selection of an optimized batch. Contour plots are presented for the selected dependant variables. PEG was found to be more effective in increasing the drug dissolution compared to PVP. Wettability study was carried out for the pure drug and optimized batch. FT-IR spectroscopy, microscopic study, differential scanning calorimetry and X-ray diffraction study were carried out in order to characterize the drug in solid dispersions. Improved dissolution was attributed to decreased crystallinity of the drug, improved wetting and solubilizing effects of carriers such as PEG and PVP from the solid dispersion of etoricoxib. In conclusion, dissolution of etoricoxib can be modulated using appropriate levels of hydrophilic carriers.